0001683168-24-005773.txt : 20240815 0001683168-24-005773.hdr.sgml : 20240815 20240815161418 ACCESSION NUMBER: 0001683168-24-005773 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240813 FILED AS OF DATE: 20240815 DATE AS OF CHANGE: 20240815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Infarinato Robert M. CENTRAL INDEX KEY: 0002032518 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 241212593 MAIL ADDRESS: STREET 1: C/O PHIO PHARMACEUTICALS CORP. STREET 2: 11 APEX DRIVE, SUITE 300A, PMB 2006 CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 APEX DRIVE, SUITE 300A STREET 2: PMB 2006 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 11 APEX DRIVE, SUITE 300A STREET 2: PMB 2006 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 4 1 ownership.xml X0508 4 2024-08-13 0 0001533040 Phio Pharmaceuticals Corp. PHIO 0002032518 Infarinato Robert M. C/O PHIO PHARMACEUTICALS CORP. 11 APEX DRIVE, SUITE 300A, PMB 2006 MARLBOROUGH MA 01752 0 1 0 0 VP, Chief Financial Officer 0 Common stock, $0.0001 par value 2024-08-13 4 A 0 8000 0 A 8000 D Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date. Includes shares of common stock underlying unvested restricted stock units. /s/ Robert M. Infarinato 2024-08-15